13 September 2017 EMA/706786/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: Octenidine dihydrochloride / phenoxyethanol

Procedure no.: PSUSA/00002199/201701

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

octeniphen®

not available

48448.00.00

SCHÜLKE & MAYR GMBH

DE

octenisept

not available

UP/I-530-09/11-02/86

SCHÜLKE & MAYR GMBH

HR

octenisept

not available

UP/I-530-09/11-02/87

SCHÜLKE & MAYR GMBH

HR

octenisept

not available

UP/I-530-09/11-02/88

SCHÜLKE & MAYR GMBH

HR

Octenisept külsőleges oldat

not available

OGYI-T-22688/01

ALLEGRO KFT

HU

Octenisept külsőleges oldat

not available

OGYI-T-22688/02

ALLEGRO KFT

HU

Octenisept külsőleges oldat

not available

OGYI-T-22688/03

ALLEGRO KFT

HU

Octenisept külsőleges oldat

not available

OGYI-T-22688/04

ALLEGRO KFT

HU

Octenisept külsőleges oldat

not available

OGYI-T-22688/05

ALLEGRO KFT

HU

OCTENISEPT® WUND-

not available

46428.00.00

SCHÜLKE & MAYR GMBH

DE

not available

882515

SURGITECH AS

EE

not available

95061.00.00

DR. AUGUST WOLFF GMBH &

DE

Vaginaltherapeutikum

DESINFEKTION octenisept 1 mg/20 mg/ml, nahalahus Wolffisept 1 mg/g + 10 mg/g Gel

CO. KG ARZNEIMITTEL

Octenisept® WD

not available

63739.00.00

SCHÜLKE & MAYR GMBH

DE

Maxiseptic, 1 mg/ml + 20

PL/H/0403/001

23613

PHARMASWISS ČESKÁ

PL

mg/ml, roztwór na skórę

REPUBLIKA S.R.O.

Octenisept Kožní roztok

not available

32/558/08-C

SCHÜLKE & MAYR GMBH

CZ

OCTENISEPT

not available

43890/07

PHARMEX S.A.

GR

List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

Page 2/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

octenisept-Lösung zur Wund-

not available

1-20402

SCHÜLKE & MAYR GESMBH

AT

not available

LT/1/14/3640/001

UAB APITERAPIJA

LT

not available

LT/1/14/3640/002

UAB APITERAPIJA

LT

not available

LT/1/14/3640/003

UAB APITERAPIJA

LT

not available

LT/1/14/3640/004

UAB APITERAPIJA

LT

not available

LT/1/14/3640/005

UAB APITERAPIJA

LT

not available

022083

T.C.CHRISTOFOROU LTD.

CY

Octiset, κολπικό διάλυμα

not available

022084

T.C.CHRISTOFOROU LTD.

CY

Septi-Wolff 1 mg/g + 20

not available

95062.00.00

DR. AUGUST WOLFF GMBH &

DE

not available

5282256

und Schleimhautdesinfektion oktiseptas 1 mg/20 mg/ml odos tirpalas oktiseptas 1 mg/20 mg/ml odos tirpalas oktiseptas 1 mg/20 mg/ml odos tirpalas oktiseptas 1 mg/20 mg/ml odos tirpalas oktiseptas 1 mg/20 mg/ml odos tirpalas Octiset Προϊόν συνδυασμού: 0,1 g διυδροχλωρικής οκτενιδίνης/2,0 g φαινοξυαιθανόλης ανά 100 g Δερματικό διάλυμα

mg/g Spray Octiset, 1 mg/ml + 20

CO. KG ARZNEIMITTEL

mg/ml, Solução cutânea

BSG PHARMACEUTICALS-

PT

PRODUTOS FARMACÊUTICOS INOVADORES, S.A.

Octiset, 1 mg/ml + 20

not available

mg/ml, Solução cutânea

5282207

BSG PHARMACEUTICALS-

PT

PRODUTOS FARMACÊUTICOS INOVADORES, S.A.

List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

Page 3/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

Octiset, 1 mg/ml + 20

not available

5282231

BSG PHARMACEUTICALS-

PT

mg/ml, Solução cutânea

PRODUTOS FARMACÊUTICOS INOVADORES, S.A.

Octiset, 1 mg/ml + 20

not available

5282215

mg/ml, Solução cutânea

BSG PHARMACEUTICALS-

PT

PRODUTOS FARMACÊUTICOS INOVADORES, S.A.

Octiset, 1 mg/ml + 20

not available

5282249

mg/ml, Solução cutânea

BSG PHARMACEUTICALS-

PT

PRODUTOS FARMACÊUTICOS INOVADORES, S.A.

Octiset, 1 mg/ml + 20

not available

5282223

mg/ml, Solução cutânea

BSG PHARMACEUTICALS-

PT

PRODUTOS FARMACÊUTICOS INOVADORES, S.A.

OCTENISEPT (0,10 g + 2,00

not available

13036

SCHÜLKE & MAYR GMBH

PL

not available

95060.00.00

DR. AUGUST WOLFF GMBH &

DE

g )/100g, plyn Wolffisept 1 mg/g + 20 mg/g Spray

CO. KG ARZNEIMITTEL

octenisept®

not available

1997070007

SCHÜLKE & MAYR GMBH

LU

octenisept

not available

4645/2004/01

SCHÜLKE & MAYR GESMBH

RO

OCTENISEPT soluție cutanată

not available

4645/2004/02

SCHÜLKE & MAYR GESMBH

RO

OCTENISEPT soluție cutanată

not available

4645/2004/03

SCHÜLKE & MAYR GESMBH

RO

octenisept® farblos

not available

46427.00.00

SCHÜLKE & MAYR GMBH

DE

Octenisept® 0,1g/100g kožní

not available

32/462/12-C

SCHÜLKE & MAYR GMBH

CZ

sprej, roztok

List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

Page 4/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

ОКТЕКЕЪР 1 mg/ml + 20

PL/H/0401/001

20170004

PHARMASWISS ČESKÁ

BG

mg/ml спрей за кожа,

REPUBLIKA S.R.O.

разтвор Duoseptic 1 mg/20 mg/ml

PL/H/0401/001

LT/1/17/4024/001

odos purškalas (tirpalas) Duoseptic 1 mg/20 mg/ml

LT

REPUBLIKA S.R.O. PL/H/0401/001

LT/1/17/4024/002

odos purškalas (tirpalas) Maxiseptic, 1 mg/ml + 20

PHARMASWISS ČESKÁ PHARMASWISS ČESKÁ

LT

REPUBLIKA S.R.O. PL/H/0401/001

23659

mg/ml, aerozol na skórę,

PHARMASWISS ČESKÁ

PL

REPUBLIKA S.R.O.

roztwór Linoseptic 1 mg/g + 10 mg/g

DE/H/3491/002

86409.00.00

Gel Linoseptic 1 mg/g + 10 mg/g

DR. AUGUST WOLFF GMBH &

DE

CO. KG ARZNEIMITTEL DE/H/3491/002

32/401/14-C

Gel

DR. AUGUST WOLFF GMBH &

CZ

CO. KG ARZNEIMITTEL

Linoseptic 1 mg/10 mg/g geel

DE/H/3491/002

857514

Linoseptic 1 mg/g + 10 mg/g

DE/H/3491/002

OGYI-T-22734/03

DE/H/3491/002

14-0256

DR. AUGUST WOLFF GMBH &

EE

CO. KG ARZNEIMITTEL Gél Linoseptic 1 mg/g + 10 mg/g

DE/H/3491/002

LT/1/14/3646/001

LV

DR. AUGUST WOLFF GMBH &

LT

CO. KG ARZNEIMITTEL DE/H/3491/002

136065

Gel Linoseptic

DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL

Gelis Linoseptic 1 mg/g + 10 mg/g

HU

CO. KG ARZNEIMITTEL

Gels Linoseptic 1 mg/g + 10 mg/g

DR. AUGUST WOLFF GMBH &

DR. AUGUST WOLFF GMBH &

AT

CO. KG ARZNEIMITTEL DE/H/3491/002

22639

DR. AUGUST WOLFF GMBH &

PL

CO. KG ARZNEIMITTEL octenisept®

not available

48447.00.00

SCHÜLKE & MAYR GMBH

DE

Vaginaltherapeutikum

List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

Page 5/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

octeniphen®

not available

46425.00.00

SCHÜLKE & MAYR GMBH

DE

octenisept 1mg/20mg/ml uz

not available

15-0171

INTERLUX , SIA

LV

DE/H/3491/001/DC

86408.00.00

DR. AUGUST WOLFF GMBH &

DE

ādas lietojams šķīdums Linoseptic 1 mg/g + 20 mg/g Spray zur Anwendung auf der

CO. KG ARZNEIMITTEL

Haut, Lösung Linoseptic 1 mg/g + 20 mg/g

DE/H/3491/001

32/402/14-C

Kožní sprej, roztok Linoseptic 1 mg/20 mg/g

CZ

CO. KG ARZNEIMITTEL DE/H/3491/001/DC

857414

Nahasprei, Lahus Linoseptic 1 mg/g + 20 mg/g

DR. AUGUST WOLFF GMBH & DR. AUGUST WOLFF GMBH &

EE

CO. KG ARZNEIMITTEL DE/H/3491/001/DC

14-0257

Uz ādas izsmidzināms

DR. AUGUST WOLFF GMBH &

LV

CO. KG ARZNEIMITTEL

aerosols, šķīdums Linoseptic 1 mg/g + 20 mg/g

DE/H/3491/001/DC

136066

Spray zur Anwendung auf der

DR. AUGUST WOLFF GMBH &

AT

CO. KG ARZNEIMITTEL

Haut, Lösung Linoseptic

DE/H/3491/001/DC

22640

DR. AUGUST WOLFF GMBH &

PL

CO. KG ARZNEIMITTEL Linoseptic 1 mg/g + 20 mg/g

DE/H/3491/001

OGYI-T-22734/02

külsőleges oldatos spray Linoseptic 1 mg/g + 20 mg/g

DE/H/3491/001

OGYI-T-22734/01

DE/H/3491/001/DC

LT/1/14/3646/003

HU

DR. AUGUST WOLFF GMBH &

LT

CO. KG ARZNEIMITTEL DE/H/3491/001/DC

LT/1/14/3646/002

not available

95063.00.00

Odos purškalas (tirpalas) Septi-Wolff 1 mg/g + 10

DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL

Odos purškalas (tirpalas) Linoseptic 1 mg/20 mg/g

HU

CO. KG ARZNEIMITTEL

külsőleges oldatos spray Linoseptic 1 mg/20 mg/g

DR. AUGUST WOLFF GMBH &

DR. AUGUST WOLFF GMBH &

LT

CO. KG ARZNEIMITTEL

mg/g Gel List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

DR. AUGUST WOLFF GMBH &

DE

CO. KG ARZNEIMITTEL

Page 6/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

OCTENISEPT®

not available

46433.00.00

SCHÜLKE & MAYR GMBH

DE

not available

H/16/02241/001

SCHÜLKE & MAYR GMBH

SI

not available

H/16/02241/002

SCHÜLKE & MAYR GMBH

SI

not available

H/16/02241/003

SCHÜLKE & MAYR GMBH

SI

not available

H/16/02241/004

SCHÜLKE & MAYR GMBH

SI

DE/H/3849/001

89796.00.00

SCHÜLKE & MAYR GMBH

DE

DE/H/3849/001

PL 05536/0001

SCHÜLKE & MAYR GMBH

UK

DE/H/3849/001

OGYI-T-22900/01

SCHÜLKE & MAYR GMBH

HU

DE/H/3849/001

OGYI-T-22900/02

SCHÜLKE & MAYR GMBH

HU

DE/H/3849/001

49126

SCHÜLKE & MAYR GMBH

SE

DE/H/3849/001/DC

32/0049/16-S

SCHÜLKE & MAYR GMBH

SK

ANTISEPTIKUM VOR KATHETERISIERUNG DER HARNBLASE Ofenosept 1 mg/20 mg v 1 ml dermalno pršilo, raztopina Ofenosept 1 mg/20 mg v 1 ml dermalno pršilo, raztopina Ofenosept 1 mg/20 mg v 1 ml dermalna raztopina Ofenosept 1 mg/20 mg v 1 ml dermalna raztopina Ophenic 1 mg/ml + 20 mg/ml Spray zur Anwendung auf der Haut, Lösung Octenisept 1 mg/ml + 20 mg/ml cutaneous spray, solution Ophenic 1 mg/ml + 20 mg/ml külsőleges oldatos spray Ophenic 1 mg/ml + 20 mg/ml külsőleges oldatos spray Ophenic 1 mg/ml + 20 mg/ml kutan spray, lösning Octenisept 1 mg/ml + 20 mg/ml Dermálna roztoková aerodisperzia

List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

Page 7/8

Product Name

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

(in authorisation country)

Number

Number

Member State

product is authorised

Оцтенисерт 1 mg/ml + 20

DE/H/3849/001

20150367

SCHÜLKE & MAYR GMBH

BG

DE/H/3849/001

042703013

SCHÜLKE & MAYR GMBH

IT

DE/H/3849/001

042703025

SCHÜLKE & MAYR GMBH

IT

DE/H/3849/001

15-0267

SCHÜLKE & MAYR GMBH

LV

DE/H/3849/001

910416

SCHÜLKE & MAYR GMBH

EE

DE/H/3849/001

H/16/02181/001

SCHÜLKE & MAYR GMBH

SI

DE/H/3849/001

H/16/02181/002

SCHÜLKE & MAYR GMBH

SI

DE/H/3849/001

LT/1/15/3802/001

SCHÜLKE & MAYR GMBH

LT

DE/H/3849/001

LT/1/15/3802/002

SCHÜLKE & MAYR GMBH

LT

not available

32834.00.00

SCHÜLKE & MAYR GMBH

DE

mg/ml спрей за кожа, разтво Octenisept 1 mg/ml + 20 mg/ml spray cutaneo, soluzione Octenisept 1 mg/ml + 20 mg/ml spray cutaneo, soluzione Ophenic 1 mg/ml + 20 mg/ml uz ādas izsmidzināms aerosols, šķīdums Ophenic, 1 mg/20 mg/ml nahasprei, lahus Ophenic 1 mg/20 mg v 1 ml dermalno pršilo, raztopina Ophenic 1 mg/20 mg v 1 ml dermalno pršilo, raztopina Ophenic 1 mg / 20 mg / ml odos purškalas (tirpalas) Ophenic 1 mg / 20 mg / ml odos purškalas (tirpalas) octenisept®

List of nationally authorised medicinal products Octenidine dihydrochloride / phenoxyethanol - PSUSA/00002199/201701 EMA/706786/2017

Page 8/8

octenidine dihydrochloride / phenoxyethanol - European Medicines ...

Sep 13, 2017 - Wolffisept 1 mg/g + 10 mg/g. Gel not available. 95061.00.00. DR. AUGUST WOLFF GMBH &. CO. KG ARZNEIMITTEL. DE. Octenisept® WD not available. 63739.00.00. SCHÜLKE & MAYR GMBH. DE. Maxiseptic, 1 mg/ml + 20 mg/ml, roztwór na skórę. PL/H/0403/001. 23613. PHARMASWISS ČESKÁ.

129KB Sizes 41 Downloads 231 Views

Recommend Documents

octenidine dihydrochloride - phenoxyethanol: CMDh scientific ...
Oct 28, 2017 - Package Leaflet. •. Section 2. Use with care in newborn babies, especially those born prematurely. may cause serious skin lesions. Remove excess product and make sure that the . does not remain on the skin longer than necessary (in

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human medicines highlights - February 2017 - European Medicines ...
To receive each new issue of the newsletter, please click here RSS feeds, choose 'Human medicines · highlights newsletter' and then click on 'Subscribe to this ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Human medicines highlights - March 2017 - European Medicines ...
For a list of RSS readers please refer to our RSS guide and follow the instructions .... WEB-RADR workshop report: mobile technologies and social media as.

Human medicines highlights - January 2017 - European Medicines ...
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Human medicines highlights - February 2018 - European Medicines ...
Key information for patients, consumers and healthcare professionals. Published monthly by the European Medicines Agency. An agency of the European Union. HUMAN MEDICINES. HIGHLIGHTS. Issue 107. February 2018. This newsletter is addressed primarily t

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

amitriptyline hydrochloride / chlordiazepoxide - European Medicines ...
Sep 29, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © European ...